Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer

OBJECTIVE: Better biomarkers are needed in order to identify patients with endometrial carcinoma at risk of recurrence and who may profit from a more aggressive treatment regimen. Our objective was to explore the applicability of plasma growth differentiation factor 15 (GDF-15) as a marker for recur...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Engerud, Hilde, Hope, Kirsten, Berg, Hege Fredriksen, Fasmer, Kristine Eldevik, Tangen, Ingvild Løberg, Haldorsen, Ingfrid Salvesen, Trovik, Jone, Krakstad, Camilla
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333370/
https://ncbi.nlm.nih.gov/pubmed/30645608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0210585
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg